Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Acxiom Corporation (ACXM - Analyst Report) reported Non-GAAP earnings per share of 22 cents in the fourth quarter of fiscal 2012 compared with 21 cents in the previous-year quarter, beating our Zacks Consensus Estimate of 19 cents.
For fiscal 2012, Non-GAAP earnings per share came in at 76 cents compared with 68 cents in fiscal 2011.
Revenues
Total revenue came in at $287.3 million, remaining almost consistent with the last year quarter but rising 2.2% sequentially. This again beat the Zacks Consensus Estimate of $281 million.
The Marketing and Data Services segment sales increased nearly 5.2% annually to $202.9 million. The company’s IT Infrastructure Management segment fell around 9.6% annually to reach $67.6 million. Other revenues dropped 14.3% year over year to $16.8 million during the quarter.
For fiscal 2012, net sales were $1.13 billion, rising 1.5% from fiscal 2011.
Margins
Operating margin (without unusual items) for the quarter came in at 12.1% versus 11.7% in the previous year quarter and 11% in the last quarter.
Marketing and Data Services operating margin was around 14.6% compared to 15.1% in the previous year quarter. The IT Infrastructure Management segment produced an operating margin of 8.7%, rising from 7.4% in the fourth quarter of fiscal 2011. Other Services operating margin came in at (3.8%) versus (5.5%) in the previous year quarter.
For fiscal 2012, operating margin (without unusual items) came in at 10.3% compared to 9.8% in the previous year.
Share Repurchase
Acxiom repurchased 1.6 million shares in the quarter for $23 million. A total of 5.6 million shares were bought back by the company for $66 million in its fiscal year 2012.
Balance Sheet and Cash Flows
Acxiom ended the quarter with cash and cash equivalents of $229.6 million, rising from $146 million at the end of the previous quarter. Net trade accounts receivable came in at $169.4 million, falling marginally from $171 million at the end of the third quarter of fiscal 2012.
Long-term debt came in at $251.9 million, falling from $257 million at the end of the third quarter of fiscal 2012. Deferred revenues came in at $60 million, falling from $70 million at the end of the previous quarter of fiscal 2012.
The company generated net cash from operations of $56.4 million during the fourth quarter of fiscal 2012 compared to $42 million in the previous year quarter. Capital expenditures incurred came in at $12.4 million during the quarter.
Outlook
For fiscal 2013, the company expects to undergo several management and investment changes which would pace up yields substantially. EPS is expected to fall within a range of 55 cents – 65 cents for the full year whereas revenues are projected to be consistent to marginally down compared to fiscal year 2012.
Get the full Analyst Report on ACXM - FREE